Evofem Biosciences (EVFM) EBT Margin (2020 - 2026)
Evofem Biosciences' EBT Margin was -419.14% in Q2 2026, down 382.31 percentage points from -36.83% a year earlier but up 188.87 percentage points from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) EBT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Evofem Biosciences' EBT Margin was -84.72% through Jun 30, 2026, down 48.64 percentage points year-over-year; for FY2025, it was 1.95%, up 47.70 percentage points from FY2024.
- EBT Margin shows a five-year change of +31908.90 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -45.76% in FY2024 (-336.66 pp), 290.90% in FY2023 (+746.17 pp), -455.27% in FY2022 (+2033.51 pp) and -2488.78% in FY2021 (+29418.17 pp).
- Quarterly EBT Margin has moved between -4601.10% (Q4 2022) and 1405.10% (Q3 2022) over five years.
- Compared with a year earlier, EBT Margin was higher in four of the last eight quarters, with an average year-over-year change of -272.08 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q4 2021 (a gain of 22720.36 percentage points); the worst was Q4 2022 (a drop of 3157.18 percentage points).
- Per Business Quant data, EVFM's EBT Margin in the three quarters before Q2 2026 was -608.01% (Q1 2026), 29.15% (Q4 2025) and -31.76% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn | -4.34% |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | -419.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -419.14% |
| Mar 31, 2026 | -608.01% |
| Dec 31, 2025 | 29.15% |
| Sep 30, 2025 | -31.76% |
| Jun 30, 2025 | -36.83% |
| Mar 31, 2025 | 113.14% |
| Dec 31, 2024 | -42.75% |
| Sep 30, 2024 | -52.78% |
| Jun 30, 2024 | 32.67% |
| Mar 31, 2024 | -133.47% |
| Dec 31, 2023 | -43.69% |
| Sep 30, 2023 | 1,291.39% |
| Jun 30, 2023 | -348.05% |
| Mar 31, 2023 | -40.47% |
| Dec 31, 2022 | -4,601.10% |
| Sep 30, 2022 | 1,405.10% |
| Jun 30, 2022 | -2,087.50% |
| Mar 31, 2022 | -750.06% |
| Dec 31, 2021 | -1,443.92% |
| Sep 30, 2021 | -4,325.99% |
API Access
Evofem Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();